October 29th at 4pm PT / 7pm ET.

Panelists

• Samir Hanash – MD Anderson Cancer Center
  Dr. Samir Hanash is a Professor of Clinical Cancer Prevention at The University of Texas MD Anderson Cancer Center. He leads the Red and Charline McCombs Institute for Cancer Early Detection and Treatment as Director and Distinguished Chair, focusing on proteomics-based diagnostics and blood biomarkers. As the Human Proteome Organization's (HUPO) inaugural president and United States Human Proteome Organization (U.S. HUPO) founder, he advances rigorous biomarker validation and multi-protein panels for clinical use.

• Bogdan Budnik – Harvard Wyss Institute

  Dr. Bogdan Budnik is a Principal Scientist at Harvard University’s Wyss Institute for Biologically Inspired Engineering. With over 20 years in mass-spectrometry-based proteomics, he leads the Biomarker and Drug Discovery Laboratory to advance diagnostics and therapeutics. His research integrates ultra-sensitive technologies with multi-omics for biomarker discovery in early disease detection. He chairs the Human Proteome Organization’s (HUPO) Single-Cell Proteomics and Artificial Intelligence initiatives and serves as Biology/Disease-driven Human Proteome Project Chair and Executive Committee member at HUPO.

• Khatereh Motamed – Thermo Fisher Scientific

  Dr. Khatereh Motamed is a senior leader in proteomics translational research and product marketing. She serves as Senior Global Product Marketing Manager at Thermo Fisher Scientific. She chairs the Human Proteome Organization’s (HUPO) Industry Advisory Board and serves on the United States Human Proteome Organization’s (U.S. HUPO) advisory board. Her expertise drives scalable proteomics solutions for research and clinical labs.